Ampio Pharmaceuticals, Inc.
AMPEDelisted Apr 4, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411906
Ampio Pharmaceuticals, Inc. was delisted on Apr 4, 2024; its insiders filed their last Form 4 on Jun 13, 2023; 28 institutions reported holding it in 13F filings for Q1 2024, worth $34.2K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Ampio Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 114 | 1 | 97 | −16 |
| Shares | 30.4M | 96.6K | 29.6M | −738.2K (−2.4%) |
| Value | $5.41M | $16.0K | $1.77M | −$3.63M (−67.3%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Shilanski & Associates, Inc. | 937,237 | $57.0K | 0.02% |
| Northcape Wealth Management, LLC | 98,000 | $6.00K | 0.00% |
| Buckingham Strategic Partners | 20,000 | $1.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,020 | $0 | 0.00% |
Sold out (20)
Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ergoteles LLC | 957,800 | $161.0K |
| Citadel Advisors LLC | 662,947 | $111.0K |
| Renaissance Technologies LLC | 435,900 | $73.0K |
| Price T Rowe Associates Inc | 394,100 | $66.0K |
| ACT Capital Management, LLC | 291,500 | $49.0K |
| D. E. Shaw & Co., Inc. | 121,374 | $20.0K |
| Charles Schwab Investment Management Inc | 73,284 | $13.0K |
| Park Avenue Securities LLC | 73,600 | $12.0K |
| Transform Wealth, LLC | 33,382 | $6.00K |
| Balyasny Asset Management LLC | 32,480 | $5.00K |
| Y-Intercept (Hong Kong) Ltd | 27,522 | $5.00K |
| Legal & General Group Plc | 15,181 | $3.00K |
| Cetera Advisor Networks LLC | 21,422 | $3.00K |
| Cubist Systematic Strategies, LLC | 17,872 | $3.00K |
| Sawtooth Solutions, LLC | 11,076 | $2.00K |
| Hoylecohen, LLC | 10,000 | $2.00K |
| Focused Wealth Management, Inc | 10,000 | $2.00K |
| New York State Common Retirement Fund | 1,666 | $0 |
| Royal Bank of Canada | 608 | $0 |
| MUFG Americas Holdings Corp | 1,665 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| NTB Financial Corp | 96,571 | $16.0K |